ALSO READ: Serum Institute's Covovax approved by DCGI for children aged 7 to 12 years The Drugs Controller General of India (DCGI) granted emergency use authorisation to the Biological E's Corbevax for 5-12 year old and Bharat Biotech's Covaxin for minors belonging to the age group of 6-12 years recently.
The Subject Expert Committee (SEC) on COVID-19 on 25 June recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to 11 years.
A week later DCGI approved the SII vaccine. Covovax (Novavax) is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of 90 per cent, according to SII, Pune.
Last year in December, the government had cleared Covovax for restricted use in an emergency situation in adults and in the 12 to 17 years age group subject to certain conditions on 9 March.